New Phase 3 Positive Results for Olanzapine LAI and Real-World Data on UZEDY® November 4, 2024 November 4, 2024
Ultrasensitive In Vitro and Ex Vivo Tracking of 13C-Labeled PEG–PLA Degradation Products by MALDI-TOF Mass Spectrometry October 23, 2024 October 23, 2024
Revisiting the nature and pharmacodynamics of tacrolimus metabolites September 27, 2024 September 27, 2024
New Efficacy, Safety, and Tolerability Data from Pivotal Phase 3 of Olanzapine LAI September 23, 2024 September 23, 2024
Presentation at the H.C. Wainwright 26th Annual Global Investment Conference (New York, September 9 to 11) September 5, 2024 September 5, 2024
Olanzapine LAI: No PDSS Observed After Completion of c.99% of the Targeted Injections for Submission September 5, 2024 September 5, 2024
Progress in the Development of the Products Portfolio and the R&D Pipeline September 3, 2024 September 3, 2024
